TBPH Suspended by BTIG - Analyst Rating Remains Neutral

gurufocus.com · 2026-09-24

Theravance Biopharma (TBPH) Analyst Rating Update On September 24, 2026, BTIG analyst Julian Harrison announced the suspension of coverage for Theravance Bio

Read the full story at gurufocus.com →